★ Organization
Novo Nordisk
Business · Pharmaceuticals & Healthcare
- Sectors
- 1
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, specializing in treatments for diabetes, obesity, and other serious chronic diseases. The company is a global leader in insulin and GLP-1 receptor agonist therapies, with products marketed worldwide. It is majority-controlled by Novo Holdings A/S, which holds a dominant share of its voting rights.